| 000 | 01410 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518004544.0 | ||
| 264 | 0 | _c20190610 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a2543-6031 | ||
| 024 | 7 |
_a10.5603/ARM.2018.0041 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSiniorakis, Eftychios | |
| 245 | 0 | 0 |
_aChronic obstructive pulmonary disease and sacubitril: explore the role of neprilysin before its inhibition. _h[electronic resource] |
| 260 |
_bAdvances in respiratory medicine _c |
||
| 300 |
_a255-256 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAminobutyrates _xtherapeutic use |
| 650 | 0 | 4 |
_aAngiotensin Receptor Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aBiphenyl Compounds |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeprilysin _xtherapeutic use |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xtherapy |
| 650 | 0 | 4 |
_aRenin-Angiotensin System _xdrug effects |
| 650 | 0 | 4 |
_aTetrazoles _xtherapeutic use |
| 650 | 0 | 4 | _aValsartan |
| 700 | 1 | _aArvanitakis, Spyridon | |
| 700 | 1 | _aElkouris, Maximilianos | |
| 700 | 1 | _aKalogirou, Stamatia | |
| 700 | 1 | _aVeldekis, Dimitrios | |
| 700 | 1 | _aLimberi, Sotiria | |
| 773 | 0 |
_tAdvances in respiratory medicine _gvol. 86 _gno. 5 _gp. 255-256 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5603/ARM.2018.0041 _zAvailable from publisher's website |
| 999 |
_c28995385 _d28995385 |
||